The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
The natural course of idiopathic pulmonary fibrosis (IPF) is variable. Predicting disease progression and survival in IPF is important for treatment. We previously demonstrated that serum periostin has the potential to be a prognostic biomarker for IPF. Our aim was to use monomeric periostin in a mu...
Main Authors: | Shoichiro Ohta, Masaki Okamoto, Kiminori Fujimoto, Noriho Sakamoto, Koichiro Takahashi, Hiroshi Yamamoto, Hisako Kushima, Hiroshi Ishii, Keiichi Akasaka, Junya Ono, Ayami Kamei, Yoshinori Azuma, Hisako Matsumoto, Yukie Yamaguchi, Michiko Aihara, Takeshi Johkoh, Atsushi Kawaguchi, Masao Ichiki, Hironori Sagara, Jun-Ichi Kadota, Masayuki Hanaoka, Shin-Ichiro Hayashi, Shigeru Kohno, Tomoaki Hoshino, Kenji Izuhara, Consortium for Development of Diagnostics for Pulmonary Fibrosis Patients (CoDD-PF) |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5371347?pdf=render |
Similar Items
-
Recent developments regarding periostin in bronchial asthma
by: Kenji Izuhara, et al.
Published: (2015-09-01) -
Serum Periostin: A Novel Biomarker for Asthma Management
by: Hisako Matsumoto
Published: (2014-01-01) -
Pathological Roles and Clinical Usefulness of Periostin in Type 2 Inflammation and Pulmonary Fibrosis
by: Junya Ono, et al.
Published: (2021-07-01) -
Periostin: From Pathogenesis to Clinical Application in Allergic Diseases
by: Kenji Izuhara
Published: (2014-01-01) -
Periostin in Allergic Inflammation
by: Kenji Izuhara, et al.
Published: (2014-01-01)